1,043 results

1. pENN.AAV.CamKII0.4.eGFP.WPRE.rBG (AAV5)

   Viral Prep

   #105541-AAV5

   Purpose

   Ready-to-use AAV5 particles produced from pENN.AAV.CamKII0.4.eGFP.WPRE.rBG (#105541). In addition to the viral particles, you will also receive purified pENN.AAV.CamKII0.4.eGFP.WPRE.rBG plasmid DNA. Expression of EGFP from CamKII promoter. These AAV preparations are suitable purity for injection into animals.

   Depositor

   James M. Wilson

   Promoter

   CaMKII

   Tags

   EGFP

   Available Since

   Aug. 2, 2018

   Availability

   Academic Institutions and Nonprofits only

2. pAAV-Ef1a-Con/Fon-BFP (AAV8)

   Viral Prep

   #137129-AAV8

   Purpose

   Ready-to-use AAV8 particles produced from pAAV-Ef1a-Con/Fon-BFP (#137129). In addition to the viral particles, you will also receive purified pAAV-Ef1a-Con/Fon-BFP plasmid DNA. EF1a-driven, Cre and Flp-dependent expression of BFP. These AAV preparations are suitable purity for injection into animals.

   Depositor

   INTRSECT 2.0 Project, Karl Deisseroth

   Article

   Fenno et al Neuron. 2020 Jun 20. pii: S0896-6273(20)

   Promoter

   EF1a

   Tags

   BFP (Cre and Flp-dependent)

   Available Since

   April 8, 2021

   Availability

   Academic Institutions and Nonprofits only

3. pAAV-Syn-Archon1-KGC-GFP-ER2 (AAV8)

   Viral Prep

   #115892-AAV8

   Purpose

   Ready-to-use AAV8 particles produced from pAAV-Syn-Archon1-KGC-GFP-ER2 (#115892). In addition to the viral particles, you will also receive purified pAAV-Syn-Archon1-KGC-GFP-ER2 plasmid DNA. Syn-driven Archon1, an opsin-based fluorescent voltage indicator, fused to EGFP. These AAV preparations are suitable purity for injection into animals.

   Depositor

   Edward Boyden

   Article

   Piatkevich et al Nat Chem Biol. 2018 Feb 26. pii: 10.1038

   Promoter

   Syn

   Tags

   GFP

   Available Since

   Feb. 28, 2019

   Availability

   Academic Institutions and Nonprofits only

4. paavCAG-post-mGRASP-2A-dTomato (AAV5)

   Viral Prep

   #34912-AAV5

   Purpose

   Ready-to-use AAV5 particles produced from paavCAG-post-mGRASP-2A-dTomato (#34912). In addition to the viral particles, you will also receive purified paavCAG-post-mGRASP-2A-dTomato plasmid DNA. CAG-driven expression of post-synaptic mGRASP-2A-dTomato for synaptic connectivity mapping. These AAV preparations are suitable purity for injection into animals.

   Depositor

   Jinhyun Kim

   Article

   Kim et al Nat Methods. 2011 Dec 4;9(1):96-102. doi

   Promoter

   CAG

   Tags

   dTomato

   Available Since

   Aug. 7, 2025

   Availability

   Academic Institutions and Nonprofits only

5. paavCAG-pre-mGRASP-mCerulean (AAV5)

   Viral Prep

   #34910-AAV5

   Purpose

   Ready-to-use AAV5 particles produced from paavCAG-pre-mGRASP-mCerulean (#34910). In addition to the viral particles, you will also receive purified paavCAG-pre-mGRASP-mCerulean plasmid DNA. CAG-driven expression of presynaptic mGRASP-mCerulean for synaptic connectivity mapping. These AAV preparations are suitable purity for injection into animals.

   Depositor

   Jinhyun Kim

   Article

   Kim et al Nat Methods. 2011 Dec 4;9(1):96-102. doi

   Promoter

   CAG

   Tags

   mCerulean

   Available Since

   Aug. 7, 2025

   Availability

   Academic Institutions and Nonprofits only

6. pAAV_BiVIPe4_ChR2_mCherry (AAV PHP.eB)

   Viral Prep

   #213856-PHPeB

   Purpose

   Ready-to-use AAV PHP.eB particles produced from pAAV_BiVIPe4_ChR2_mCherry (#213856). In addition to the viral particles, you will also receive purified pAAV_BiVIPe4_ChR2_mCherry plasmid DNA. Expression of mCherry-tagged channelrhodopsin-2 under the control of the VIP interneuron-targeting enhancer E4. These AAV were produced with the PHPeB serotype, which permits efficient transduction of the central nervous system. These AAV preparations are suitable purity for injection into animals.

   Depositor

   Gordon Fishell

   Article

   Furlanis et al Neuron. 2025 May 21;113(10):1525-1547.e1

   Promoter

   Tags

   mCherry

   Available Since

   Dec. 2, 2024

   Availability

   Academic Institutions and Nonprofits only

7. AiP13038 - pAAV-AiE0743m_3xC2-minBG-SYFP2-WPRE3-BGHpA (Alias: CN3038) (AAV PHP.eB)

   Viral Prep

   #191720-PHPeB

   Purpose

   Ready-to-use AAV PHP.eB particles produced from AiP13038 - pAAV-AiE0743m_3xC2-minBG-SYFP2-WPRE3-BGHpA (Alias: CN3038) (#191720). In addition to the viral particles, you will also receive purified AiP13038 - pAAV-AiE0743m_3xC2-minBG-SYFP2-WPRE3-BGHpA (Alias: CN3038) plasmid DNA. SYFP2 expression in striatal and lateral septum cholinergic neurons. These AAV were produced with the PHPeB serotype, which permits efficient transduction of the central nervous system. These AAV preparations are suitable purity for injection into animals.

   Depositor

   Jonathan Ting, The Allen Institute for Brain Science

   Article

   Hunker et al Neuron. 2025 May 21;113(10):1507-1524.e1

   Promoter

   Tags

   SYFP2

   Available Since

   July 15, 2024

   Availability

   Academic Institutions and Nonprofits only

8. pGP-AAV-GFAP-iGABASnFR2-WPRE (AAV5)

   Viral Prep

   #218871-AAV5

   Purpose

   Ready-to-use AAV5 particles produced from pGP-AAV-GFAP-iGABASnFR2-WPRE (#218871). In addition to the viral particles, you will also receive purified pGP-AAV-GFAP-iGABASnFR2-WPRE plasmid DNA. GFAP-driven expression of the improved GABA sensor iGABASnFR2 (positive change in fluorescence). These AAV preparations are suitable purity for injection into animals.

   Depositor

   GENIE Project

   Article

   Kolb et al bioRxiv 2025.03.25.644953

   Promoter

   GFAP

   Tags

   None

   Available Since

   Sept. 27, 2024

   Availability

   Academic Institutions and Nonprofits only

9. pAAV_EF1a-DIO-PdCO-mScarlet-ER-miniWPRE (AAV1)

   Viral Prep

   #198516-AAV1

   Purpose

   Ready-to-use AAV1 particles produced from pAAV_EF1a-DIO-PdCO-mScarlet-ER-miniWPRE (#198516). In addition to the viral particles, you will also receive purified pAAV_EF1a-DIO-PdCO-mScarlet-ER-miniWPRE plasmid DNA. Ef1a-driven, Cre-dependent expression of the optimized opsin PdCO in frame with mScarlet. These AAV preparations are suitable purity for injection into animals.

   Depositor

   Ofer Yizhar

   Article

   Wietek et al Nat Methods. 2024 May 29. doi: 10.1038/s

   Promoter

   EF-1a

   Tags

   mScarlet

   Available Since

   April 10, 2024

   Availability

   Academic Institutions and Nonprofits only

10. pAAV-CAG-2xNLS-tdTomato-WPRE-hGHpolyA (AAV PHP.eB)

    Viral Prep

    #192552-PHPeB

    Purpose

    Ready-to-use AAV PHP.eB particles produced from pAAV-CAG-2xNLS-tdTomato-WPRE-hGHpolyA (#192552). In addition to the viral particles, you will also receive purified pAAV-CAG-2xNLS-tdTomato-WPRE-hGHpolyA plasmid DNA. CAG-driven expression of nuclear localized tdTomato. These AAV were produced with the PHPeB serotype, which permits efficient transduction of the central nervous system. These AAV preparations are suitable purity for injection into animals.

    Depositor

    Guoping Feng

    Promoter

    CAG

    Tags

    tdTomato

    Available Since

    June 26, 2024

    Availability

    Academic Institutions and Nonprofits only

11. pAAV CD68-hM4D(Gi)-mCherry (AAV9)

    Viral Prep

    #75033-AAV9

    Purpose

    Ready-to-use AAV9 particles produced from pAAV CD68-hM4D(Gi)-mCherry (#75033). In addition to the viral particles, you will also receive purified pAAV CD68-hM4D(Gi)-mCherry plasmid DNA. CD68-driven hM4D(Gi) receptor with an mCherry reporter for CNO-induced microglial inhibition. These AAV preparations are suitable purity for injection into animals.

    Depositor

    Bryan Roth

    Article

    Grace et al Proc Natl Acad Sci U S A. 2016 Jun 14;11

    Promoter

    CD68

    Tags

    mCherry

    Available Since

    Sept. 27, 2023

    Availability

    Academic Institutions and Nonprofits only

12. AiP14825: pAAV-AiE0441h_3xC2-minBG-iCre(R297T)-BGHpA (Alias: CN4825) (AAV PHP.eB)

    Viral Prep

    #214862-PHPeB

    Purpose

    Ready-to-use AAV PHP.eB particles produced from AiP14825: pAAV-AiE0441h_3xC2-minBG-iCre(R297T)-BGHpA (Alias: CN4825) (#214862). In addition to the viral particles, you will also receive purified AiP14825: pAAV-AiE0441h_3xC2-minBG-iCre(R297T)-BGHpA (Alias: CN4825) plasmid DNA. minBG-driven expression of iCre(R297T) in striatal medium spiny neurons. These AAV were produced with the PHPeB serotype, which permits efficient transduction of the central nervous system. These AAV preparations are suitable purity for injection into animals.

    Depositor

    Jonathan Ting, The Allen Institute for Brain Science

    Article

    Hunker et al Neuron. 2025 May 21;113(10):1507-1524.e1

    Promoter

    Tags

    None

    Available Since

    Nov. 13, 2024

    Availability

    Academic Institutions and Nonprofits only

13. pAAV-hSyn-dLight1.1 (AAV1)

    Viral Prep

    #111066-AAV1

    Purpose

    Ready-to-use AAV1 particles produced from pAAV-hSyn-dLight1.1 (#111066). In addition to the viral particles, you will also receive purified pAAV-hSyn-dLight1.1 plasmid DNA. hSyn-driven expression of dLight1.1 dopamine sensor. These AAV preparations are suitable purity for injection into animals.

    Depositor

    Lin Tian

    Article

    Patriarchi et al Science. 2018 Jun 29;360(6396). pii: sci

    Promoter

    Tags

    None

    Available Since

    Oct. 28, 2021

    Availability

    Academic Institutions and Nonprofits only

14. pENN.AAV.EF1a.eGFP.WPRE.rBG (AAV1)

    Viral Prep

    #105547-AAV1

    Purpose

    Ready-to-use AAV1 particles produced from pENN.AAV.EF1a.eGFP.WPRE.rBG (#105547). In addition to the viral particles, you will also receive purified pENN.AAV.EF1a.eGFP.WPRE.rBG plasmid DNA. EF1a-driven EGFP expression. These AAV preparations are suitable purity for injection into animals.

    Depositor

    James M. Wilson

    Promoter

    EF1a

    Tags

    EGFP

    Available Since

    Sept. 13, 2021

    Availability

    Academic Institutions and Nonprofits only

15. pAAV-hSyn-GRAB_g5-HT3.0 (AAV1)

    Viral Prep

    #208717-AAV1

    Purpose

    Ready-to-use AAV1 particles produced from pAAV-hSyn-GRAB_g5-HT3.0 (#208717). In addition to the viral particles, you will also receive purified pAAV-hSyn-GRAB_g5-HT3.0 plasmid DNA. Synapsin-driven expression of GRAB_g5-HT3.0 sensor. These AAV preparations are suitable purity for injection into animals.

    Depositor

    Yulong Li

    Article

    Deng et al bioRxiv 2023.05.27.542566

    Promoter

    Syn

    Tags

    None

    Available Since

    Aug. 7, 2025

    Availability

    Academic Institutions and Nonprofits only

16. pAAV.GFA104.PI.eGFP.WPRE.bGH (AAV5)

    Viral Prep

    #100896-AAV5

    Purpose

    Ready-to-use AAV5 particles produced from pAAV.GFA104.PI.eGFP.WPRE.bGH (#100896). In addition to the viral particles, you will also receive purified pAAV.GFA104.PI.eGFP.WPRE.bGH plasmid DNA. GFA104-driven eGFP expression. These AAV preparations are suitable purity for injection into animals.

    Depositor

    Philip Haydon

    Article

    Ortinski et al Nat Neurosci. 2010 May;13(5):584-91. doi

    Promoter

    GFA104 (GFAP promoter)

    Tags

    EGFP

    Available Since

    April 6, 2018

    Availability

    Academic Institutions and Nonprofits only

17. pAAV-CaMKIIa-EGFP (AAV2)

    Viral Prep

    #50469-AAV2

    Purpose

    Ready-to-use AAV2 particles produced from pAAV-CaMKIIa-EGFP (#50469). In addition to the viral particles, you will also receive purified pAAV-CaMKIIa-EGFP plasmid DNA. CamKIIa-driven EGFP expression control. These AAV preparations are suitable purity for injection into animals.

    Depositor

    Bryan Roth

    Promoter

    CaMKII

    Tags

    EGFP

    Available Since

    Jan. 6, 2022

    Availability

    Academic Institutions and Nonprofits only

18. pAAV-CaMKIIa-C1V1 (t/t)-TS-EYFP (AAV9)

    Viral Prep

    #35499-AAV9

    Purpose

    Ready-to-use AAV9 particles produced from pAAV-CaMKIIa-C1V1 (t/t)-TS-EYFP (#35499). In addition to the viral particles, you will also receive purified pAAV-CaMKIIa-C1V1 (t/t)-TS-EYFP plasmid DNA. CaMKIIa-driven, C1V1 (t/t) fused to EYFP for optogenetic activation. These AAV preparations are suitable purity for injection into animals.

    Depositor

    Karl Deisseroth

    Article

    Yizhar et al Nature. 2011 Jul 27;477(7363):171-8. doi

    Promoter

    CaMKII

    Tags

    EYFP

    Available Since

    April 6, 2018

    Availability

    Academic Institutions and Nonprofits only

19. pAAV-Ef1a-mCherry (AAV5)

    Viral Prep

    #114470-AAV5

    Purpose

    Ready-to-use AAV5 particles produced from pAAV-Ef1a-mCherry (#114470). In addition to the viral particles, you will also receive purified pAAV-Ef1a-mCherry plasmid DNA. EF1a-driven mCherry expression. These AAV preparations are suitable purity for injection into animals.

    Depositor

    Karl Deisseroth

    Promoter

    EF1a

    Tags

    mCherry

    Available Since

    Sept. 15, 2021

    Availability

    Academic Institutions and Nonprofits only

20. pAAV_hsyn_NES-his-CaMPARI2-F391W-WPRE-SV40 (AAV1)

    Viral Prep

    #101061-AAV1

    Purpose

    Ready-to-use AAV1 particles produced from pAAV_hsyn_NES-his-CaMPARI2-F391W-WPRE-SV40 (#101061). In addition to the viral particles, you will also receive purified pAAV_hsyn_NES-his-CaMPARI2-F391W-WPRE-SV40 plasmid DNA. Synapsin-driven, photoconvertible (irreversible green-to-red) calcium integrator his-tagged CaMPARI2-F391W. These AAV preparations are suitable purity for injection into animals.

    Depositor

    Eric Schreiter

    Article

    Moeyaert et al Nat Commun. 2018 Oct 25;9(1):4440. doi:

    Promoter

    Syn

    Tags

    None

    Available Since

    July 23, 2018

    Availability

    Academic Institutions and Nonprofits only